FDA panel votes against COVID-19 booster recommendation
| A federal advisory panel said Friday the Food and Drug Administration (FDA) should not approve a third booster dose of Pfizer and BioNTech’s COVID-19 vaccine for everyone 16 or older, but indicated they would be open to boosters for older people. |
